With reference to CDSL’s Operating Instructions for Issuers/RTAs which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed, Panacea Biotec has informed that no share has been dematerialized during the month of March, 2024. The company has confirmed that the total number of shares dematerialized as on March 31, 2024, were as under: NSDL - 5,30,27,436, CDSL - 80,60,089 = 6,10,87,525 (Total). A copy of the certificate obtained from the Company’s RTA - Skyline Financial Services, regarding shares dematerialized as on March 31, 2024 is also enclosed as Annexure - 1.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: